1. 3 Things You Should Know About Geographic Atrophy

2. This program will include a discussion of off-label and investigational agents not approved by the FDA for use in the United States.

3. Geographic Atrophy: A Clinician's Challenge

4. AREDS Classification Early and Intermediate AMD

5. Advanced AMD: "Wet" vs "Dry"

6. Affects of GA on Vision

7. Rate of GA Progression

8. Treatability: CNV vs GA

9. Therapeutic Approaches Visual Cycle Modulation

10. Therapeutic Approaches Anti-Amyloid ß Therapy

11. Therapeutic Approaches Neuroprotection

12. Therapeutic Approaches Suppress Inflammation/Complement Inhibition

13. Therapeutic Approaches Components of the Complement System

14. Factor D Inhibition: Lampalizumab

15. C3 Inhibition: APL-2

16. Therapeutic Approaches Stem Cell Therapy

17. Early GA Detection is Key

18. Fundus Photography

19. Autofluorescence Imaging

20. SD OCT

21. Fluorescein Angiography

22. Tracking the Progression of GA

23. 3 Key Takeaways